william a. miller, pharm.d., msc, fashp, fccp professor emeritus, university of iowa
TRANSCRIPT
![Page 1: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/1.jpg)
William A. Miller, Pharm.D., MSc, FASHP, FCCPProfessor Emeritus, University of Iowa
![Page 2: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/2.jpg)
2
At the conclusion of this presentation you will be able to
Critically evaluate the effectiveness of your current practice model
Construct a practice model that focuses on optimizing patient care outcomes and safety
Use new strategies to expand clinical pharmacy services
Consider changes in your leadership and management skills to improve your effectiveness
![Page 3: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/3.jpg)
Ideally individuals in executive or director positions have both excellent leadership and manager skills
Anyone can be a leader Leaders set the direction for the organization and influences people
to follow that direction. Managers follow the direction for the organization and implement programs, and achieve goals and objectives set by leaders
Leaders do the right thing and managers do things right Leaders set direction by developing a clear vision and mission, and
conducting planning that determines the goals needed to achieve the vision and mission. They motivate or influence people by using various methods: facilitation, coaching, mentoring, directing, delegating, and rewarding
![Page 4: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/4.jpg)
The manager administers; the leader innovates. The manager is a copy; the leader is an original. The manager imitates; the leader originates. The manager focuses on systems and structure; the leader
focuses on people. The manager relies on control; the leader inspires trust, The manager has a short-range view; the leader has a long-
range perspective. The manager focuses on the bottom line; the leader has an
eye on the horizon. The manager accepts the status quo; the leader challenges it. The manager is the classic good soldier; the leader is his or her
own person. The manager does things right; the leader does the right thing.
![Page 5: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/5.jpg)
Clear vision Develop an administrative team with unity of purpose and
values Surround themselves with other individuals who have
complimentary skills Proactive versus reactive: Seek to expand circle of influence
(Avoid saying “if only”) Good communications skills (Respected by able to disarm
people and put at ease for communications) Build relationships with key leaders: administration, medical,
nursing, etc. Value different perspectives: Good listeners Develop a positive departmental structure: openness, value of
every staff member, Cultivates the “I and we will attitude” High performance expectations (model and expect of staff)
![Page 6: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/6.jpg)
1. Pharmacy leaders set the direction for the department
2. Leaders do things right and managers do the right thing
3. Mangers have a short term view and leaders have a long term view
4. Pharmacy leaders have a clear vision5. Pharmacy leaders build relationships with
other hospital leaders
![Page 7: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/7.jpg)
Mission of the department of pharmacy Vision for the department of pharmacy Values of the department of pharmacy Goals of the department of pharmacy
◦ Short term goals: annual (one to 2 years)◦ Long term goals: 3 to 5 years◦ Goals are broad: Establish decentralized pharmacy services
Objectives aimed at achieving goals◦ Example: Establish decentralized pharmacy services for all
critical care services by 6/2011 Actions plans are detailed steps to achieve a specific
objective with dates and accountable person Actions plans lead to implementation and achievement of
goals and objectives
![Page 8: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/8.jpg)
Perceived value of pharmacists as providers of patient care (“Providers”)
Leadership Health care and pharmacy practice models Qualifications and credentialing of pharmacists as
patient care providers Required standard of care: Best practices Present information technology/automation Funding of cognitive services
![Page 9: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/9.jpg)
Develop an organizational chart matched to vision Develop administrative team with shared values Hire competent staff for all positions Engage staff in planning and decision making Elevate qualifications for providers of clinical
services: Residency, board certification Credential and privilege pharmacists: Scope of
practice as patient care providers. Develop a pharmacy practice model matched to
the vision Use automation and technology effectively
![Page 10: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/10.jpg)
Use pharmacy technicians to reduce pharmacist involvement in distributive and other technical duties
Development systems to improve medication-use-systems
Champion improvements for the medication-use-system
Align clinical services with regulatory requirements and quality organizations
Align clinical services with funding opportunities Align clinical services with institutional plans Align pharmacy practice model to medical
practice model
![Page 11: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/11.jpg)
What strategy are you planning or presently implementation to increase the quality or quantity of clinical pharmacy services provided by your department?
![Page 12: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/12.jpg)
• Assure optimal drug therapy outcomes• Effective drug therapy• Safe drug therapy• Cost-effective drug therapy
• Assure pharmaceutical care is coordinated and provided collaboratively with other pharmaceutical care providers
• Assure effective relationships with patients that lead to patient involvement, understanding, adherence
• Assure efficient and patient focused delivery of care
![Page 13: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/13.jpg)
13
Abundant number of publications documenting the value of clinical services in inpatient and outpatient settings◦ Most pharmacists in published studies were full
time clinical pharmacists on interdisciplinary teams (i.e., generalists or specialists) and not pharmacy generalists in an integrated system (i.e., performing distributive as well as clinical functions)
◦ Need for research comparing integrated, hybrid and coordinated practice models
![Page 14: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/14.jpg)
14
Is specialized medical care better than care provided by generalists?
Is interdisciplinary team care better than care provided by one discipline?
Should pharmacists all have the same KSA or have different KSA?
Should pharmacy teams be multidisciplinary like medical teams? (pharmacy generalists, clinical specialists, compounding specialists, informatics specialists, safety specialists)
Can clinical pharmacy specialists have the same job description as clinical pharmacists?
![Page 15: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/15.jpg)
– Variable: Comprehensive to minimal– Comprehensive more likely in medium to large
hospitals– Diffusion of ADC for drug dispensing– Diffusion of decentralized pharmacists but variable
quality and quantity of clinical services provided.– Adoption and diffusion of clinical pharmacy services
has been slow
![Page 16: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/16.jpg)
Rogers EM. Diffusion of Innovations
![Page 17: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/17.jpg)
A
B
Rogers EM. Diffusion of Innovations
Move up the curve
Shift the curve to the left
![Page 18: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/18.jpg)
Core Clinical Pharmacy Services• Medication profile review to identify and address drug
related problems• Target drug monitoring• Provision of drug information as requested• Participation in medical codes• Participation in patient care unit team meetings• Participation in drug policy development• Medication reconciliation as needed• Patient discharge counseling as needed
![Page 19: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/19.jpg)
Advanced and Specialized Clinical Pharmacy Services• Prospective or concurrent treatment planning through
consistent participation on formalized interdisciplinary teams (rounds)
• Comprehensive medication therapy management through P&T approved protocols for monitoring drug therapy and changing drug therapy (hospital wide or department/division specific) or collaborative practice agreements
• Clinical specialists (usually PGY1 residency and PGY2 in specialized practice areas: Critical Care, Oncology, Transplantation, Cardiology, Infectious Diseases)
![Page 20: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/20.jpg)
Expansion of health care (Most agree about the benefits of expanding health care coverage)
Reduction in health care costs: (All agree need to reduce costs of health care)
A lot of the public want expanded health care benefits but don’t want to pay for it.
No interest group wants to be negatively impacted
![Page 21: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/21.jpg)
• Potential Opportunities ◦ Team based care (Medical Home Model, Accountable
Care Organizations)– Continuity/transitions of care/prevention of hospital
readmissions/prevention– Medication therapy management services and
medication reconciliation– Expanded use of technology and automation to
improve safety and efficiency– Implementation of new reimbursement models– Testing of various models to deliver care (comparative
effectiveness research) Need to take advantage of these opportunities
as health reform moves forward
![Page 22: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/22.jpg)
Potential threats• Inadequate funding of clinical services (fee for service or
portion of funding provided to support patient care or a new reimbursement method)
• Impact of cost reductions on funding of clinical services (delayed implementation, reduction in services)
• Use of other providers to provide pharmaceutical care because of political and/or economic reasons
![Page 23: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/23.jpg)
1. Evidence of the value of teams is sufficient2. Evidence of the value of clinical pharmacy
services is insufficient3. The diffusion of clinical pharmacy services,
as an innovation, was quite rapid4. Inadequate funding of clinical pharmacy
services as a part of health care reform is a potential threat to pharmacy
5. The “Medical Home Model” may provide an opportunity to expand clinical services in ambulatory care settings
![Page 24: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/24.jpg)
24
Model◦ Model is defined as “structural design of something”◦ Organizational chart reflects the practice model or
structure being used for the delivery of pharmacy services
System◦ A group of interacting, interrelated, or interdependent
elements forming a whole◦ A system for the delivery of pharmacy services reflects
the practice model used Ideal Practice Model
◦ Allows achievement of the desired pharmacy service mission, goals and objectives while adhering to core values
![Page 25: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/25.jpg)
25
Integrated model◦ One pharmacist job description◦ All pharmacists provide distributive and clinical
services concurrently◦ Pharmacists rotate to central and decentralized
practice areas
![Page 26: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/26.jpg)
26
Hybrid model◦ Central and decentralized pharmacist roles under one job
description: Selected central pharmacists assigned to decentralized role on a rotating basis
◦ Decentralized pharmacists may only focus on target monitoring and other clinical services, have concurrent distributive responsibilities and rotate to central area to staff
![Page 27: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/27.jpg)
27
Coordinated model ◦ Multiple job descriptions with different roles and
responsibilities: Centralize pharmacist, decentralized or clinical pharmacist, clinical specialist
◦ Pharmacists supportive of various roles, capable (not proficient) to perform different roles, and care is coordinated (team approach) to achieve common goals
![Page 28: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/28.jpg)
28
Beliefs of pharmacy leadership which are based upon experiences, training, values and opinions of thought leaders and organizations
Number and quality of staff Use of information technology and
automation Nursing, physician and hospital
administration beliefs and support
![Page 29: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/29.jpg)
29
Consultant recommendations Politics Model development
◦ Evolve by adding clinical to distributive services◦ Rarely redesign of existing model but tweek of
existing◦ Usually driven by beliefs and subjective opinions ◦ Lack of evidence-based research on effectiveness
of practice models and metrics for staffing to make practice model design decision making more objective
![Page 30: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/30.jpg)
30
Similar goals for pharmacy services:◦ Safe drug distribution and medication use system◦ Quality clinical services
Difference in service emphasis◦ Safe drug distribution system maybe emphasized
or viewed as being more important than influence on the quality of pharmaceutical care
◦ Are dispensing errors more significant than prescribing errors?
◦ As pharmacy clinicians with good leadership and management skills are appointed pharmacy directors will clinical services be emphasized?
![Page 31: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/31.jpg)
31
Different definitions of quality clinical services◦ Target drug monitoring and cost reductions as
outcomes (Often see in integrated models)◦ Pharmacists on interdisciplinary teams share
responsibility for drug therapy outcomes with physicians and other providers (Often see with coordinated models)
Different assessment of the level of clinical services actually being provided by the department
![Page 32: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/32.jpg)
32
Director
Pharmacists
Central staffingrotation
Decentralized staffingrotation
![Page 33: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/33.jpg)
33
Director
Central Pharmacists
Select CentralPharmacists:
Targeted Monitoringand MTM
![Page 34: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/34.jpg)
34
Director
Assistant DirectorCentral Pharmacy
CoordinatorClinical Services
Assistant DirectorOutpatient Services
OutpatientDispensingPharmacists
CentralPharmacists
DecentralizedPharmacists
ClinicalSpecialists
ClinicalSpecialists
![Page 35: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/35.jpg)
35
Director
Assistant DirectorInpatient Services
Assistant DirectorOutpatient Services
CentralizedServices/Lead
DecentralizedServices/Lead
Clinical Pharmacists
Clinical Specialists
Central Pharmacists
Centralized Services/Lead
OutpatientPharmacists
Clinical Specialists
![Page 36: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/36.jpg)
![Page 37: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/37.jpg)
37
CHIEF PHARMACY
OFFICER
DirectorTransplantation
Services
DirectorMedical and
SurgeryServices
DirectorOncology Services
Team Leaders forClinical Pharmacists
and Specialists
DirectorPediatric Services
Team Leaders forClinical Pharmacists
and Specialists
DirectorPsychiatry Services
DirectorOutpatient Services
DirectorCentral Inpatient
Pharmacy Services
Team Leaders forClinical Pharmacists
and SpecialistsFurther organization Central Pharmacists
Team Leaders forClinical Pharmacists
and Specialists
Team Leaders forClinical Pharmacists
and Specialists
![Page 38: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/38.jpg)
![Page 39: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/39.jpg)
39
Advantages of Integrated Practice Models◦ Recruitment of pharmacists to provide clinical services easier
because larger applicant pool◦ Scheduling of pharmacists easier◦ Staff morale maybe enhanced because all pharmacists have the
same responsibilities and status◦ Greater percent of patients may receive core clinical services
Disadvantages of Integrated Practice Models◦ Minimal level of clinical services may result (e.g., new order
review, target monitoring, drug information)◦ Patient populations needing advanced patient care services
maynot receive sufficient services◦ Pharmacists may not become essential members of
interdisciplinary teams and as a result miss opportunities to improve patient outcomes
![Page 40: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/40.jpg)
40
Advantages of Coordinated Practice Models◦ Pharmacists on interdisciplinary teams provide
advanced/specialized clinical services as essential team members
◦ Clinical services provided to interdisciplinary teams better (specialized knowledge, skills and abilities; greater awareness of pertinent patient safety issues for the specific patient population, repetition/proficiency)
◦ Better use of pharmacist knowledge, skills and abilities (PGY1 and PGY2 residency training) leading to improved employee satisfaction
Disadvantages of Coordinated Practice Models◦ Creates scheduling problems◦ Replacement of pharmacists more difficult◦ Silos may develop and impair effectiveness of internal
pharmacy team while enhancing interdisciplinary teams
![Page 41: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/41.jpg)
41
Core clinical services should be provided to all patients. Specialized/advanced clinical services must be available to all
patients requiring these services Clinical services should be consistently provided The model for the overall delivery of pharmacy services must
be efficient, effective and coordinated (team approach). The model must fit the system used by the hospital and/or
medical staff for delivering patient care. Providers of all pharmacy services must be competent. An appropriate mix of staff with needed KSA must be
employed The model must result in a safe medication use system. The model must result in pharmacists being essential patient
care providers and members of formalized interdisciplinary teams.
Pharmacy residents must be included in the model as appropriate
The model must result in a positive department culture, and high morale and retention rates.
![Page 42: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/42.jpg)
Briefly describe your current practice model and then answer the following questions.
How have you assessed the effectiveness of your current practice model?
How are you planning to change your practice model to further optimize patient care outcomes and safety?
![Page 43: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/43.jpg)
43
Containment (Subsystems): Practice models used by physicians and nurses need to be considered in deciding on pharmacy practice model◦ Teaching hospitals with formalized
interdisciplinary teams and house staff different than community hospital model with private physicians and no formalized teams
Ripple Effect of Change:◦ Changing the type of pharmacists hired for
decentralized pharmacy positions affects outcomes of the whole system
![Page 44: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/44.jpg)
44
Synergy: If all parts of the practice model are working well and together, synergy is achieved (optimum drug distribution, patient care, drug policy and medication use systems)
![Page 45: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/45.jpg)
45
Rule of the weakest link: ◦ Hiring a director who views pharmacy as a material
management versus a clinical department affects mission and vision for patient care services to be provided by pharmacists
◦ Placing unqualified pharmacists in clinical roles impacts overall system (patient care outcomes diminished)
◦ Assigning a critical care pharmacist 50 patients or a decentralized pharmacist 150 patients to provide distributive and clinical services affects type and amount of cognitive services provided
◦ Rotating pharmacists to different areas (central, patient care) affects ability of pharmacists to become essential members of interdisciplinary teams
![Page 46: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/46.jpg)
46
Different Perspectives on How to Design the Best Pharmacy Practice Model to Optimize Patient Outcomes◦ Patient care effectiveness◦ Patient care safety◦ Efficiency of care (quality/costs)
Balance of outcomes
![Page 47: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/47.jpg)
47
Cognitive services to be provided◦ Core clinical services◦ Specialized/advanced clinical services
Prospective involvement in establishing patient treatment plans versus routine monitoring
Collaborative drug and disease state management◦ Core and specialized/advanced services will need to
change for pharmacy to continue to add value to health care Specialized/advanced services today will become future
core services Specialized/advanced services in the future will be affected
by advances in health care, new drugs, pharmacogenomics, advanced decision support systems
![Page 48: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/48.jpg)
48
Model Effect on Cognitive Services Provided Cognitive Domain Affective
Domain
Evaluation
Synthesis
Analysis
Application
Comprehension
Knowledge
Characterization
Organization
Valuing
Responding
Receiving
![Page 49: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/49.jpg)
49
Reviewing routine orders: Low to medium Target drug monitoring: Low to medium Managing anticoagulation: Low to medium Developing best practice guidelines,
protocols: High Determining best treatment plan for a
critical care patient with multiple disease states: High
![Page 50: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/50.jpg)
50
Patient care acuity and complexity◦ Quaternary and tertiary care versus secondary
care◦ Type of patient care unit: Intensive care and
emergency department, step down or intermediate care, general patient care
Size of the inpatient or ambulatory patient population◦ Size affects overall staff resources needed to
provide comprehensive pharmacy services: inadequate staffing compromises level of clinical services.
![Page 51: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/51.jpg)
51
Number of patients per clinical pharmacist or specialist ◦ Currently see150 to 30 for regular patient care
units, ICUs: 60 to 10◦ The higher the patient number the less involved
pharmacists are in the care of individual patients◦ Lack of pharmacy metrics◦ Miller Numbers for Optimal Clinical Services: ICUs
20 maximum, patient care units, 40 maximum◦ Numbers affect the ability to use an integrated
service practice model for all clinical pharmacists
![Page 52: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/52.jpg)
52
Use of pharmacy technicians for order fulfillment◦ Medication histories and reconciliation◦ Tech-tech programs◦ Routine clinical monitoring
Use of automation and use of information technologies available to increase efficiency and safety of medication use systems◦ CPOE◦ Access to information: PC, Tablets, Remote◦ Pharmacy computer system: SOAP, monitoring data,
evidenced-based recommendations◦ Use of ADC as unit dose carts◦ Use of order scanning technologies◦ Use of bar-coding and electronic-MARs◦ Decision support
![Page 53: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/53.jpg)
53
Physician and nursing practice models◦ Interdisciplinary teams in teaching hospitals versus
private practice model◦ Hospitalist model
Opinions of key leaders in the organization◦ Pharmacy, medical, nursing and administrative leaders◦ Are clinical pharmacists essential to patient care teams,
desirable, or primarily valued as a drug information resource or for teaching medical residents?
Opinions of professional organizations◦ Physician organizations: Critical care, ID, transplant,
oncology, pediatrics◦ Pharmacy organizations: ASHP Best Practices, PPMI, and
ACCP statements Organizational effectiveness research
◦ Research on best practice models
![Page 54: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/54.jpg)
Are the involved pharmacists capable of performing the new role?
Will the proposed change be perceived as adding value to the jobs of the involved pharmacists?
Will the perception by the involved pharmacists of the probability of value satisfaction from the role change be sufficient to gain their support?
The pharmacists involved must not perceive the cost of the change in role as being significant.
Involved pharmacists perception of the risk of making the change should be low.
![Page 55: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/55.jpg)
1. No one model is the best fit for all pharmacy organizations
2. The number and quality of staff affects the pharmacy practice model selected by pharmacy directors
3. Increased use of information technology and automation enhances patient safety and the delivery of clinical pharmacy services
4. All pharmacists should have the same qualifications and job descriptions
5. Chief Pharmacy Officers are more frequently appointed in large hospitals or health care systems
![Page 56: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/56.jpg)
56
Critically analyze the effectiveness and efficiency of your current practice model
Design and implement a model that◦ Optimizes the influence of pharmacy on patient
care outcomes: effectiveness, safety and efficiency
◦ Is a good fit for your institution◦ Is efficient, synergistic and coordinated
![Page 57: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/57.jpg)
57
◦ Results in pharmacists being essential members of interdisciplinary teams
◦ Places the interests of pharmacy leaders or individual pharmacists secondary to what is the best model for your patients
Develop metrics to evaluate the effectiveness and efficiency of your practice model and revise the model as needed
![Page 58: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/58.jpg)
58
1. Bennis W. On Becoming a Leader. Reading, MA: Addison-Wesley Publishing Company; 1989.
2. Bond CA: Interrelationships among mortality rates, drug costs, total cost of care, and length of stay in United States Hospitals. Pharmacotherapy 2001;21 (2): 129-141.
3. Bond CA: Clinical pharmacy services, pharmacy staffing and the total cost of care in United States hospitals. Pharmacotherapy 2000;20(6):609-21
4. Bond CA: Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals. Pharmacotherapy 2002;22 (2): 134-147
5. Economic evaluations of clinical pharmacy services-1988-1995. Pharmacotherapy 1996; 16(6): 1188-1208
6. Kaboli PJ, Hoth AB, et al.: Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med 2006; May 8;166 (9): 955-64.
7. Bond CA, Raehl CL: Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States Hospitals. Pharmacotherapy 2006 (6): 735-47.
8. Chisholm-Burns MA: US Pharmacists' Effect as Team Members on Patient Care: Systematic Review and Meta-Analyses. Medical Care: 2010; 48 (10):923-933
![Page 59: William A. Miller, Pharm.D., MSc, FASHP, FCCP Professor Emeritus, University of Iowa](https://reader036.vdocuments.site/reader036/viewer/2022062308/56649d355503460f94a0c8f2/html5/thumbnails/59.jpg)
59
9.Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice and settings: Monitoring and patient education-2009. 2010; 67 (7): 542-558.10.Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice and settings: Dispensing and administration-2008. 2009; 66 (10): 926-946.11.Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing-2007. 2008; 65 (9): 827-843.12.ASHP: PPMI (ASHP website). Accessed March 19, 2011.13.Zellmer WA. Pharmacy’s future: Transformation, diffusion, and imagination. Am J Health-Syst Pharm. 2010; 67: 1199-1204.14.Knoer S, et. A;.: Lessons learned from a pharmacy practice model change at an academic medical center. Am J Health-Syst Pharm. 2010; 67: 1862-1869.15.Abramowitz P: The evolution and metamorphosis of the pharmacy pratice model. Am J Health-Syst Pharm. 2009; 64:1437-1446.16.Breland B. Believing what we know: pharmacy provides value. Am J Health-Syst Pharm. 2007: 64:17.Dwyer CE. Managing people. In: Roven S, Ginsberg L, eds. Managing hospitals. San Francisco, CA: Jossey-Bass Publishers; 1991.